Everolimus 00054-0497-13
- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 8, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA207486
Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Everolimus | 7.5 mg/1 |
Drug Class
Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
00054-0497-13Selected30 TABLET in 1 BOTTLE (0054-0497-13)